A polished AI demonstration can make a healthcare technology decision feel simpler than it is. The system produces a convincing result, the vendor describes potential efficiency, and the leadership team sees a plausible use case. Before a board approves a pilot, however, the organization needs a more practical document: an evidence brief that explains the problem, proposed use, boundaries, risks, and decision criteria. The purpose is not to slow every experiment. It is to make the experiment capable of producing an answer that leadership can responsibly use.
Start with a specific operational problem. Describe the current workflow, the people involved, and the consequence of leaving it unchanged. Avoid beginning with a product name or a broad ambition to become an AI organization. A narrow problem statement allows the team to compare the proposed technology with other responses, including process improvement, training, or a simpler tool. If the problem cannot be described clearly without mentioning the vendor, the proposal may need more work before a pilot is ready.
Define the intended use in plain language. Explain what information enters the system, what output it produces, and what a person or another system does with that output. Identify uses that are outside the proposed scope. An administrative pilot should not quietly become a clinical decision tool because the same interface can generate additional responses. Changes in use can introduce different risks and review requirements. The evidence brief should make those boundaries visible to both executives and the people conducting the work.
Establish a baseline before estimating improvement. Identify how the current process is measured and whether the available data is reliable enough for comparison. A time estimate from a demonstration is not the same as observed performance in the organization’s workflow. Record the period, population, and assumptions behind the baseline. If the measurement is incomplete, state that limitation and explain how the pilot will address it. An uncertain starting point should not be hidden behind a precise projected benefit.
Separate vendor claims from independently observed evidence. A case study, product demonstration, reference conversation, and local evaluation each answer different questions. Record what each source actually shows and the conditions under which the result occurred. Do not assume that another organization’s outcome will transfer unchanged to a different staffing model, data environment, or patient population. The board should be able to see which statements are established, which are plausible hypotheses, and which remain untested in the intended setting.
Identify the people accountable for the pilot. Name the executive sponsor, operational owner, technical lead, and the appropriate privacy, security, compliance, legal, and clinical reviewers for the proposed use. Their involvement should reflect the actual risks rather than a generic approval list. A vendor relationship does not remove the organization’s responsibility to understand how a tool will be used. The brief should explain who can approve a change, who monitors concerns, and who has authority to pause the work.
The NIST AI Risk Management Framework offers a voluntary resource for organizing questions about trustworthy AI design, use, and evaluation. It can help a leadership team structure its discussion, but citing a framework does not certify a product or establish legal compliance. The organization still needs a review tied to its intended use, data, users, and obligations. Use the resource to improve the questions being asked, not as a substitute for evidence.
Document the data boundaries before sharing information with a tool. Ask the appropriate reviewers what data is permitted, where it will be processed, who can access it, and what retention or secondary use terms apply. Do not upload patient information, confidential business records, or personal data into an unapproved service for convenience. A demonstration can use appropriately prepared examples without exposing real records. The specific privacy and contractual requirements should be evaluated by the professionals responsible for those matters.
Design human review around the actual consequences of an error. A statement that a person remains involved is not enough if that person lacks time, information, or authority to challenge the output. Explain what the reviewer checks, how uncertainty is presented, and what happens when the output is wrong or unsupported. Consider whether the workflow encourages overreliance. The pilot should evaluate the complete process, including review burden and correction, rather than measuring only the speed at which the system produces text.
Define success before the pilot begins. Choose measures connected to the operational problem and include indicators that could reveal unacceptable tradeoffs. Faster processing may not be useful if correction work rises or important cases are missed. Avoid selecting only the metric that is easiest to improve. The brief should state how results will be collected, who will review them, and what limitations will remain. A short pilot may support a narrow conclusion without justifying deployment across every site or workflow.
Establish stopping and escalation criteria alongside success measures. Identify the kinds of incidents, performance concerns, or scope changes that require a pause or additional review. Explain how staff can raise concerns without relying on informal messages to a single project champion. A pilot should have a practical route back to an approved process if the tool is unavailable or unsuitable. Planning that route is not pessimism; it is part of making the experiment controlled and the resulting evidence interpretable.
Include the work required to operate the technology. Integration, training, supervision, exception handling, monitoring, and vendor coordination can affect the practical value of a proposal. Keep those requirements visible in the financial discussion. Do not compare a vendor’s subscription price with the full cost of the existing process while omitting the people and systems needed for the new one. Clearly labeled assumptions help the board understand which benefits depend on changes that have not yet occurred.
Peer experience can sharpen the review when it is used carefully. SCALE Community’s executive roundtable series provides a setting for healthcare leaders to discuss operating challenges and technology adoption. Ask peers about implementation conditions, unexpected work, and the evidence they found useful. Do not request confidential patient information or commercially sensitive details. A peer’s experience can reveal questions worth testing, but it does not establish that the same decision is right for your organization.
For initiatives tied to revenue cycle operations, the discussion may also involve service delivery as well as technology. SCALE Healthcare’s technology enabled RCM services illustrate that operating models can combine people, processes, and software. Evaluate any proposed arrangement against the organization’s specific requirements and the actual engagement terms. A commercial offering or general performance statement should not replace a local baseline, a defined scope, and evidence appropriate to the decision being considered.
Bring the board a decision request that is proportionate to the evidence. Approval to conduct a limited pilot is different from approval to deploy broadly or enter a continuing service commitment. State the proposed duration, resources, boundaries, review points, and authority being requested. Identify what the board will receive at the next decision point. This prevents a small initial approval from becoming an implicit endorsement of a larger program that has not been assessed.
Experienced operators can help challenge assumptions without taking over management’s responsibilities. SCALE Community’s Board Advisory offering is relevant when leaders are considering how operating experience can support governance and strategic decisions. Any advisory role should have a clear scope, appropriate conflict review, and agreed responsibilities. The value of outside perspective is not a promise that a technology decision will succeed. It is an opportunity to test the quality of the reasoning before the organization commits further.
After the pilot, preserve the evidence and record the decision honestly. Include results that did not support the original hypothesis, changes made during the test, and limitations on interpretation. Distinguish a measured outcome from an anecdote or expectation. If leadership chooses to continue, identify the conditions and additional review required. If it stops, retain the lessons rather than rewriting the project as a success. A useful governance process improves the next decision even when the initial proposal is not adopted.
A strong AI evidence brief gives a healthcare board a clear problem, a bounded proposal, accountable owners, meaningful measures, and a defensible next decision. It replaces enthusiasm alone with a practical basis for learning. Leaders who want to connect with peers or discuss the relevant SCALE Community resources can contact the SCALE Community team. Bring the operating question and the evidence gaps, not just the product name. The most productive conversation begins with what the organization needs to understand before it acts.